Lorenz Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 3.20 M
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -99.84%
- Profit Growth 68.88%
- Ebitda 67.41%
- Net Worth -26.44%
- Total Assets -33.02%
About Lorenz Life Sciences India
Lorenz Life Sciences India Private Limited (LLSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 January 2009 and has a history of 16 years. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.20 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jastine, Raoul Lorenz, and Wolfgang Witzel serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72200TN2009PTC070427
-
Company No.
070427
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jan 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Lorenz Life Sciences India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Wolfgang Witzel
|
Director | 25-Nov-2009 | Current |
|
Raoul Lorenz
|
Director | 20-Jul-2009 | Current |
Jastine
|
Director | 25-Sep-2020 | Current |
Financial Performance of Lorenz Life Sciences India.
Lorenz Life Sciences India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.84% decrease. The company also saw a substantial improvement in profitability, with a 68.88% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lorenz Life Sciences India?
In 2021, Lorenz Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Iotium Systems Private LimitedJastine is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lorenz Life Sciences India?
Unlock and access historical data on people associated with Lorenz Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lorenz Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lorenz Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
